Appearance of skin lesions in cattle populations vaccinated against lumpy skin disease: Statutory challenge

Brenner, J.; Bellaïche, M.; Gross, Elmer R.; Elad, D.; Oved, Z.; Haimovitz, M; Wasserman, Asaf; Friedgut, Orly; Stram, Yehuda; Bumbarov, V.; Yadin, Hagai

doi:10.1016/j.vaccine.2009.01.020

Cited by 99 publications

(94 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the same year, LSD was again reported in Israel, and the Israel authorities speculated that the LSD virus may have already been circulating in other Middle Eastern countries [18]. LSD outbreaks have been reported in the Middle Eastern region since 1990.…”

Section: Historymentioning

confidence: 99%

Lumpy Skin Disease

Abdulqa¹,

Rahman²,

Dyary³

et al. 2016

Reproductive Immunol Open Acc

View full text Add to dashboard Cite

Lumpy skin disease (LSD) is an infectious, eruptive, occasionally fatal disease of cattle caused by a virus of the family Poxviridae (genus Capripox), which is sometimes also termed as Neethling virus. LSD does not have a high fatality rate, usually less than 10%. LSD has an economical importance because of permanent damage to hides, the prolonged debilitating effect especially in severely affected animals with consequent losses resulting from reduced weight gain, temporary or permanent cessation of milk production as a result of mastitis, temporary or permanent infertility or even sterility in bulls as a consequence of orchitis, and abortion in approximately 10% of infected pregnant cows.

show abstract

Section: Historymentioning

confidence: 99%

Lumpy Skin Disease

Abdulqa¹,

Rahman²,

Dyary³

et al. 2016

Reproductive Immunol Open Acc

View full text Add to dashboard Cite

show abstract

“…Although LSD vaccines are widely used in the face of outbreaks in Africa, vaccine breakdown and re-infection of vaccinated animals have been reported [11,12]. In Israel approximately 11.1% of beef cattle vaccinated with the RM65 vaccine, developed cutaneous lesions after exposure to an LSDV during the 2006/07 epidemics [13]. In Egypt incomplete protection of cattle vaccinated by live attenuated KSGP O-240 strain was reported during the 2006 outbreak [14].…”

Section: Introductionmentioning

confidence: 99%

Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains against lumpy skin disease virus

Gari¹,

Abie²,

Gizaw³

et al. 2015

Vaccine

View full text Add to dashboard Cite

“…According to many studies, it has been proven that CaPV strains L share a major neutralizing site, So that animals are infected with one strain of CaPV family and survived from it, will be resistant to infection with any other strain. Therefore, the use of vaccine strains of CaPV derived from sheep and goat would be useful to protect cattle against LSD (8,11,12). Recently, live attenuated goat pox virus and sheep pox virus strains are used as vaccines for the control of LSD (13).…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Humoral and Cell-mediated Immunity of Two Capripoxvirus Vaccine Strains against Lumpy Skin Disease Virus

et al. 2016

View full text Add to dashboard Cite

Background and Aims: Prevention of Lumpy skin disease (LSD) in cattle is heavily dependent on vaccination. Since the genetic structure of LSD virus has the close relatedness with other Capri-pox virus (CaPV). Therefore, the use of vaccine strains of CaPV derived from sheep and goat would be useful to protect cattle against LSD. Materials and Methods:The susceptible calves of dairy farms were vaccinated with two available LSD vaccines. These vaccines were live attenuated sheep pox and goat pox vaccine strains. To evaluate vaccine-induced immune responses, whole blood and serum samples were collected up to 5 weeks post vaccination from both vaccinated and control groups. Results: The findings showed that, lymphocyte proliferation index in response to recall antigen in goat pox vaccine was higher than sheep pox vaccine in all time-point of experiments, and this difference was significant in weeks 1 and 5 post vaccination (p<0.05). Although the levels of antibody production in both vaccinated groups was almost the similar, and there was no statistically significant difference, but in goat pox vaccine slightly higher than sheep pox vaccine. Also, the interferon gamma and IL-4 production in goat pox vaccine were higher than sheep pox vaccine in all-time point and statistically significant at week 3 post vaccination (p< 0.05). Conclusions: From this study we found that live attenuated goat pox vaccine induced high level of lymphocyte proliferation and interferon gamma and IL-4, so it considered good vaccine to control of Lumpy skin disease.

show abstract

Appearance of skin lesions in cattle populations vaccinated against lumpy skin disease: Statutory challenge

Cited by 99 publications

References 3 publications

Lumpy Skin Disease

Lumpy Skin Disease

Evaluation of the safety, immunogenicity and efficacy of three capripoxvirus vaccine strains against lumpy skin disease virus

Evaluation of Humoral and Cell-mediated Immunity of Two Capripoxvirus Vaccine Strains against Lumpy Skin Disease Virus

Contact Info

Product

Resources

About